Results 31 to 40 of about 8,006,579 (361)

CD137: A Member of the TNFR Family - in Psoriasis Skin Lesions in Comparison with Normal Skin Specimens [PDF]

open access: yesIranian Journal of Pathology, 2021
Background and Objective: CD137 is a member of the TNF-Receptor family. TNF-alpha antagonists have therapeutic effect in active psoriasis. In this study, the relative frequency of CD137 expression was investigated in the inflammatory cells of psoriasis ...
Parvin Rajabi   +3 more
doaj   +1 more source

Destabilizing the autoinhibitory conformation of Zap70 induces up-regulation of inhibitory receptors and T cell unresponsiveness. [PDF]

open access: yes, 2017
Zap70 plays a critical role in normal T cell development and T cell function. However, little is known about how perturbation of allosteric autoinhibitory mechanisms in Zap70 impacts T cell biology.
Chen, Yiling   +4 more
core   +2 more sources

Cell-in-cell: A virgin land of cell biology [PDF]

open access: yesOncoImmunology, 2013
Cell-in-cell affects multiple functions of both internalized and internalizing cells. Immune effector cells and their targets can also interact in this fashion. We have recently investigated the outcome of cell-in-cell, the molecular mechanisms underpinning this phenomenon, and its relevance in both physiological and pathological conditions.
Ying Wang, Xiaoning Wang
openaire   +3 more sources

ATOPIC DERMATITIS: FROM MOLECULAR SPECIFICITY OF ORAL MANIFESTATIONS TO CLINICAL IMPLICATIONS

open access: yesRomanian Journal of Oral Rehabilitation, 2022
Atopic dermatitis (AD) is considered a systemic disease that also manifests itself in the oral cavity. The presence of oral pathologies in patients with atopic dermatitis can result in the worsening of the atopic disease, and on the other hand, the ...
Petronela Bărgăoanu   +4 more
doaj  

Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis

open access: yesInternational Journal of Hyperthermia, 2021
Background This study aimed to evaluate whether combined therapy with PD-1 blockade (anti-PD-1) and radiofrequency ablation (RFA) is superior to RFA monotherapy for recurrent hepatocellular carcinoma (HCC).
Xiaofei Wang   +7 more
doaj   +1 more source

Human natural killer cell committed thymocytes and their relation to the T cell lineage. [PDF]

open access: yes, 1993
Recent studies have demonstrated that mature natural killer (NK) cells can be grown from human triple negative (TN; CD3-, CD4-, CD8-) thymocytes, suggesting that a common NK/T cell precursor exists within the thymus that can give rise to both NK cells ...
Lanier, LL   +3 more
core   +1 more source

Cells within cells (within cells) [PDF]

open access: yesThe Journal of Cell Biology, 2007
![][1] Within 6 hours of detachment from their substrate, one cell becomes entirely enclosed by another. BRUGGE/ELSEVIER One tumor cell can burrow its way entirely inside another.
openaire   +2 more sources

EMMPRIN AND HUMAN β-DEFENSIN-3 – BIOMARKER MOLECULES IN PREMALIGNANT ORAL LESIONS: CORRELATIVE IMMUNOHISTOCHEMICAL STUDY

open access: yesRomanian Journal of Oral Rehabilitation, 2021
Aim of the study The current pandemic context, with a significant negative impact on the oral mucosa pathology, requires intensified research on the risk of malignant transformation of the most common premalignant oral lesions, precursors of oral ...
Doinița Temelie-Olinici   +7 more
doaj  

Peptide Super-Agonist Enhances T-Cell Responses to Melanoma

open access: yesFrontiers in Immunology, 2019
Recent immunotherapeutic approaches using adoptive cell therapy, or checkpoint blockade, have demonstrated the powerful anti-cancer potential of CD8 cytotoxic T-lymphocytes (CTL).
Sarah A. E. Galloway   +18 more
doaj   +1 more source

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies

open access: yesOncoImmunology, 2021
Based on the success of tumor-infiltrating lymphocytes (TIL)-based therapies, personalized adoptive cell therapies (ACT) targeting neoantigens have the potential to become a disruptive technology and lead to highly effective treatments for cancer ...
Florian Kast   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy